吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jun 27 2022

Full Issue

Biden Administration Gears Up To Preserve Access To Abortion Pills

The Department of Justice issued a warning that states can鈥檛 restrict access to mifepristone, as it is a FDA approved drug. But such restrictions are already on the books in 30 states.

Attorney General Merrick Garland is hinting he鈥檚 ready to get tough on states that block access to an FDA-approved pill used to terminate pregnancies. He鈥檚 got a lot of work ahead of him. On Friday, the Supreme Court ruled that the U.S. Constitution does not protect the right to an abortion, overruling the landmark 1973 Roe v. Wade decision. In response, the Justice Department declared that it will 鈥渨ork tirelessly to protect and advance reproductive freedom.鈥 Namely, it warned that states can鈥檛 restrict access to mifepristone, a drug approved by the FDA in 2000 to terminate pregnancies. (Florko, 6/24)

Immediately following the ruling, Attorney General Merrick Garland said the Justice Department will protect the right to an abortion, including medication abortion. 鈥淲e stand ready to work with other arms of the federal government that seek to use their lawful authorities to protect and preserve access to reproductive care,鈥 Garland said in a statement.聽鈥淚n particular, the [Food and Drug Administration] FDA has approved the use of the medication Mifepristone. States may not ban Mifepristone based on disagreement with the FDA鈥檚 expert judgment about its safety and efficacy,鈥 Garland said. (Weixel, 6/24)

In the hours after the Supreme Court released its decision overturning the legal right to abortion in the United States, nearly 100 requests for appointments flowed into Just the Pill, a nonprofit organization that arranges for patients to obtain abortion pills in several states. That was about four times the usual daily number of appointment requests for the organization, and many came from patients in Texas and other states that quickly halted abortions after the court ruling. (Belluck, 6/26)

With Roe's fall expected to lead to abortion being banned in about half the states, a petition launched by Allison Fine, the former chair of the national board of NARAL: Pro-Choice America Foundation, calling on the FDA to lift barriers to accessing the drugs. (Rahman, 6/26)

Following the Supreme Court's upheaval of Roe v. Wade and Planned Parenthood v. Casey, Attorney General Merrick Garland said in a statement that states cannot ban the abortion medication mifepristone.聽"And we stand ready to work with other arms of the federal government that seek to use their lawful authorities to protect and preserve access to reproductive care," he wrote.聽"In particular, the FDA has approved the use of the medication Mifepristone. States may not ban Mifepristone based on disagreement with the FDA鈥檚 expert judgment about its safety and efficacy," Garland stated.聽(Musto, 6/25)

Mifepristone might help cancer, other illnesses 鈥

Dr. Nancy Klimas has spent the better part of her three-decade research career trying to find a cure for Gulf War illness. Military veterans with the unusual, unexplained illness 聽鈥 which affects some 300,000 U.S. service members who fought in the 1991 Operation Desert Storm 鈥 suffer from a range of symptoms, including constant aches and pains, trouble concentrating, fatigue, respiratory issues and irritable bowel syndrome, all understood to stem from exposure to neurotoxic chemicals during combat. Apart from symptom management 鈥 which she says is really just 鈥渃hasing the tail of the dog鈥 鈥 there鈥檚 no treatment for Gulf War illness. And the clock is ticking: According to Klimas, director of the Institute for Neuro-Immune Medicine at Nova Southeastern University in Florida, the condition could turn into severe neurodegenerative disease if left untreated. (Hopkins, 6/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF